ACLIDINIUM BROMIDE AND FORMOTEROL FUMARTE (DUAKLIR PRESSAIR) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARTE

What is the Trade Name for ACLIDINIUM BROMIDE AND FORMOTEROL FUMARTE

DUAKLIR PRESSAIR

What is the Indication for ACLIDINIUM BROMIDE AND FORMOTEROL FUMARTE

  • 1 INDICATIONS AND USAGE DUAKLIR PRESSAIR is a combination of aclidinium bromide (an anticholinergic) and formoterol fumarate (a LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Limitations of Use : DUAKLIR PRESSAIR is not indicated for the relief of acute bronchospasm or for the treatment of asthma [see Warnings and Precautions (5.1, 5.4) ] . DUAKLIR PRESSAIR is a combination of aclidinium bromide an anticholinergic, and formoterol fumarate, a long-acting beta 2 -adrenergic agonist (LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). (1) Limitations of Use : Not indicated for the relief of acute bronchospasm or for the treatment of asthma. (1, 5.4).

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]